Status:

Do Not Prescribe (DNP), Red

Decision Date:

July 2025

Comments

RED: NICE TA1070 - Spesolimab for treating generalised pustular psoriasis flares

DNP: NICE TA1144 (Terminated appraisal): Subcutaneous spesolimab 1-ml formulation for preventing generalised pustular psoriasis flares in people 12 years and over (decision date May 2026)

Do Not Prescribe (DNP) Drug Classifications

• 6: Have NICE guidance that recommends they should not be used

search again